Showing results (131-140 of 215) with videos related to
Sort By:
Pageof 22
World Neurosurgery|January 6, 2020
A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I GliomasAlexander T Yahanda, Bhuvic Patel, Garnette Sutherland, et al.Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade GliomaJo Sasame, Naoki Ikegaya, Masahito Kawazu, et al.Journal of Neurological Surgery. Part B, Skull Base|November 22, 2019
Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum MeningiomasSally R Williams, Tareq A Juratli, Brandyn A Castro, et al.Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.Cell Stem Cell|December 20, 2016
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug ToleranceBrian B Liau, Cem Sievers, Laura K Donohue, et al.Neuropathology and Applied Neurobiology|November 20, 2021
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningiomaChristian Mirian, Kathrine Grell, Tareq A Juratli, et al.Biorxiv : the Preprint Server for Biology|April 27, 2026
KDM6 Enzymes are the Mechanistic Targets of Mutant IDH that Dictate Replication Stress SensitivityAlexander C-Y Tsai, Mathew D Lin, Vinesh T Puliyappadamba, et al.Genome Medicine|February 4, 2017
Longitudinal analysis of treatment-induced genomic alterations in gliomasE Zeynep Erson-Omay, Octavian Henegariu, S Bülent Omay, et al.Neuro-Oncology Advances|February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastomaAndrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.Pageof 22